GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $12.77 $17.80 Friday, 19th Apr 2024 ENTA stock ended at $13.32. This is 0.680% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.25% from a day low at $12.77 to a day high of $13.44.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
2023-05-26 $24.86 $25.03 $24.41 $24.89 126 639
2023-05-25 $25.27 $25.27 $24.52 $24.86 125 896
2023-05-24 $26.84 $26.84 $24.77 $25.41 196 840
2023-05-23 $27.29 $28.25 $26.89 $27.00 167 074
2023-05-22 $26.65 $27.59 $26.64 $27.41 194 833
2023-05-19 $25.45 $26.77 $25.35 $26.51 196 590
2023-05-18 $25.42 $25.48 $24.55 $25.16 192 085
2023-05-17 $24.68 $25.66 $23.91 $25.50 243 392
2023-05-16 $25.45 $25.72 $24.48 $24.64 205 833
2023-05-15 $25.20 $26.57 $25.20 $25.87 215 670
2023-05-12 $25.74 $25.74 $24.94 $25.33 150 250
2023-05-11 $25.88 $26.16 $25.33 $25.52 210 827
2023-05-10 $25.70 $26.56 $24.17 $26.51 462 271
2023-05-09 $24.00 $25.64 $23.03 $25.52 981 685
2023-05-08 $36.04 $36.04 $34.21 $34.33 155 292
2023-05-05 $36.69 $37.14 $35.80 $36.02 144 100
2023-05-04 $35.36 $36.40 $34.81 $36.30 80 583
2023-05-03 $35.16 $35.95 $34.45 $35.49 193 804
2023-05-02 $37.27 $37.27 $34.93 $35.00 222 095
2023-05-01 $35.44 $37.75 $35.43 $37.51 183 569
2023-04-28 $34.30 $35.79 $33.35 $35.55 132 272
2023-04-27 $34.56 $35.43 $33.18 $33.97 162 839
2023-04-26 $34.60 $35.14 $34.32 $34.55 167 505
2023-04-25 $36.85 $36.35 $34.65 $34.75 219 780
2023-04-24 $36.92 $37.00 $35.93 $36.37 63 062
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT